Status:

NOT_YET_RECRUITING

Towards Digital Management of Paediatric Asthma

Lead Sponsor:

Assistance Publique - Hôpitaux de Paris

Conditions:

Pediatric Asthma

Eligibility:

All Genders

4-12 years

Phase:

NA

Brief Summary

This pilot study aims to explore whether a digital approach to managing childhood asthma using connected inhalers and video consultations triggered by alerts from these devices - could work as well as...

Detailed Description

Asthma is the most common chronic illness in children. In France, two-thirds of children have uncontrolled asthma, meaning they experience symptoms and occasional asthma attacks. The digital revoluti...

Eligibility Criteria

Inclusion

  • Aged 4 to 12, whose asthma has been diagnosed by a physician
  • Followed up for their asthma by a pediatrician or pediatric pulmonologist
  • With asthma severity corresponding to GINA grades 2, 3 or 4 (Global Asthma Initiative Guidelines)
  • Whose controller and reliever treatments are administered using pressurized metered-dose inhalers (p-MDIs)
  • With social security
  • Whose parents or legal guardian(s):
  • Have given their written and informed consent for their child's participation and their participation,
  • Have a smartphone in the household that can download the application and is compatible with it,
  • Are capable, in the opinion of the investigator, of understanding the use of the mobile application and module FRENCH CARE specifically dedicated to the research and the digital inhalers provided.
  • Non-inclusion Criteria:
  • Patients with another pathology that could interfere with the evaluation of the endpoints (e.g, bronchopulmonary dysplasia, cystic fibrosis, etc.)
  • Patients whose parents or legal representative(s) are, in the opinion of the investigator, unable to understand the purpose of the study and/or express their consent.
  • Patients benefiting from State Medical Aid

Exclusion

  • \- Patient who did not use the system within 15 days of the inclusion visit

Key Trial Info

Start Date :

October 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 1 2026

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT06902766

Start Date

October 1 2025

End Date

October 1 2026

Last Update

July 20 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hôpital Necker Enfants Malades AP-HP

Paris, France, 75015